Fisher & Paykel Healthcare beats earnings guidance revenue as ‘triple-demic’ looms the in US

Fisher & Paykel Healthcare beats earnings guidance revenue as ‘triple-demic’ looms the in US
Health experts are concerned by the simultaneous spread of three respiratory illnesses in the United States. (Photo: Getty)
Dan Brunskill
Fisher & Paykel Healthcare has reported half-year earnings ahead of analyst expectations and their own market guidance, with operating revenue at $690.6 million.The company had told the market to expect revenue to be $670m in its August trading update, warning that many customers were already stocked up on hospital products.Even though the higher-than-expected revenue was 23% lower than in the first half of the prior year, it was a 21% increase on the pre-pandemic period first half of 2020.Fisher & Paykel Healthcare's (FPH) chief ex...

More Markets

'The grim reaper cometh': NZ sharemarket plummets
Markets Market Close

'The grim reaper cometh': NZ sharemarket plummets

The S&P/NZX 50 Index plunged 449.4 points or 3.68% to 11,775.88.

Graham Skellern 07 Apr 2025
$15m or more: tariff warning for Skellerup
Markets

$15m or more: tariff warning for Skellerup

Latest round of tariffs will hit key manufacturing sites hard, analyst says.

Equities savaged as China retaliates to Trump tariffs
Markets

Equities savaged as China retaliates to Trump tariffs

The NZX50 was down almost 3% at 3pm.

AFP 07 Apr 2025
S&P/ASX 200 drops more than 6% after open
Markets

S&P/ASX 200 drops more than 6% after open

The global trade war is ramping up. 

Rebecca Howard 07 Apr 2025